Airsculpt Technologies (AIRS) USD0.001

Sell:$3.90Buy:$3.94Price increased$0.40 (11.56%)

Prices delayed by at least 15 minutes
Sell:$3.90
Buy:$3.94
Change:Price increased$0.40 (11.56%)
Prices delayed by at least 15 minutes
Sell:$3.90
Buy:$3.94
Change:Price increased$0.40 (11.56%)
Prices delayed by at least 15 minutes

Company Information

About this company

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.

Key people

Michael Doyle
Non-Executive Chairman of the Board
Yogesh Jashnani
Chief Executive Officer, Director
Michael J. Arthur
Chief Financial Officer
Adam T. Feinstein
Lead Independent Director
Thomas J. Aaron
Independent Director
Caroline Chu
Independent Director
Kenneth Higgins
Independent Director
Click to see more

Key facts

  • Shares in issue
    70.55m
  • EPIC
    AIRS
  • ISIN
    US0094961002
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • Market cap
    $251.85m
  • Employees
    330
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.